Comparison of Outpatient Antimicrobial Therapy (OPAT) in a Physician Office Infusion Center (POIC) vs. Traditional Home Health Care (HHC)

Presented on October 8, 2014

Richard C. Prokesch, MD, FACP, FIDSA -Infectious Disease Associates, Riverdale, GA
John S. Adams, MD, FIDSA -Knoxville Infectious Disease Consultants, PC, Knoxville, TN
Ramesh V. Nathan, MD- Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
Claudia P. Schroeder, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX
K. Dale Hooker, PharmD – Healix Infusion Center, Inc., Knoxville, TN

View Poster View Abstract

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.